Nirmatrelvir/ritonavir use in patients with COVID-19 on hemodialysis: a case series

Patients undergoing hemodialysis (HD) are particularly vulnerable to coronavirus disease 2019 (COVID-19) and are at increased risk of developing severe infection. However, given the exclusion of such patients from clinical trials, there are limited data regarding the effectiveness of the antiviral d...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ai-hua, Diao, Zong-li, Wang, Gang, Guan, Yi-ming, Liu, Ying-jie, Tian, Dong-li, Zhao, Yu-chao, Huang, Hong-dong, Liu, Wen-hu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129908/
https://www.ncbi.nlm.nih.gov/pubmed/37677996
http://dx.doi.org/10.1016/j.diagmicrobio.2023.115969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129908/
https://www.ncbi.nlm.nih.gov/pubmed/37677996
http://dx.doi.org/10.1016/j.diagmicrobio.2023.115969

Ejemplares similares